Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.175 USD | -0.47% | +2.12% | -24.37% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 25.86M | Capitalization | 122M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -69M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.72 x |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
-2.14
x | Employees | 54 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84% |
Latest transcript on Leap Therapeutics, Inc.
1 day | -0.47% | ||
1 week | +2.12% | ||
Current month | +1.13% | ||
1 month | +21.51% | ||
3 months | -8.87% | ||
6 months | +82.27% | ||
Current year | -24.37% |
Managers | Title | Age | Since |
---|---|---|---|
Doug Onsi
CEO | Chief Executive Officer | 55 | 10-12-31 |
Chris Mirabelli
CHM | Chairman | 69 | 10-12-31 |
Jason Baum
CTO | Chief Tech/Sci/R&D Officer | 45 | 20-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
BRD | Director/Board Member | 72 | 15-12-31 |
Nissim Mashiach
BRD | Director/Board Member | 63 | 16-12-31 |
Chris Mirabelli
CHM | Chairman | 69 | 10-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 3.2 | +0.31% | 102 174 |
24-05-03 | 3.19 | +0.63% | 334,593 |
24-05-02 | 3.17 | -3.06% | 137,458 |
24-05-01 | 3.27 | +5.48% | 151,424 |
24-04-30 | 3.1 | +0.98% | 105,872 |
Delayed Quote Nasdaq, May 06, 2024 at 01:12 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.37% | 122M | |
+8.60% | 105B | |
-0.89% | 104B | |
+5.79% | 22.94B | |
-12.42% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.15% | 16.96B | |
+8.30% | 14.16B | |
+39.30% | 12.63B |
- Stock Market
- Equities
- LPTX Stock